Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in Leishmania infantum
Summary: Antileishmanial chemotherapy is currently limited due to severe toxic side effects and drug resistance. Hence, new antileishmanial compounds based on alternative approaches, mainly to avoid the emergence of drug resistance, are needed. The present work aims to decipher the mechanism of acti...
Автори: | Sameh Obeid, Eloisa Berbel-Manaia, Valérie Nicolas, Indira Dennemont, Julien Barbier, Jean-Christophe Cintrat, Daniel Gillet, Philippe M. Loiseau, Sébastien Pomel |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Elsevier
2023-11-01
|
Серія: | iScience |
Предмети: | |
Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2589004223022216 |
Схожі ресурси
Схожі ресурси
-
Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB
за авторством: Yolanda Pérez-Pertejo, та інші
Опубліковано: (2019-12-01) -
Leishmania infantum asymptomatic infection in inflammatory bowel disease patients under anti-TNF therapy
за авторством: M. Carmen Guillén, та інші
Опубліковано: (2020-05-01) -
Leishmania amazonensis sabotages host cell SUMOylation for intracellular survival
за авторством: Kendi Okuda, та інші
Опубліковано: (2022-09-01) -
Antileishmanial Activity of BNIPDaoct- and BNIPDanon-loaded Emulsomes on Leishmania infantum Parasites
за авторством: Zeynep Islek, та інші
Опубліковано: (2022-01-01) -
The different impact of drug-resistant Leishmania on the transcription programs activated in neutrophils
за авторством: Míriam Díaz-Varela, та інші
Опубліковано: (2024-05-01)